Ed Cadman
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 7
-
- Lymphoma Diagnosis and Treatment 7
- Genetics top 5%
- Hematology top 5%
-
- Lung Cancer Treatments and Mutations 7
-
- Biochemical and Molecular Research 20
- Cancer therapeutics and mechanisms 5
-
- Acute Lymphoblastic Leukemia research 7
-
- HIV/AIDS drug development and treatment 6
Ed Cadman
57 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 92
- Oncology 696
- Pathology and Forensic Medicine 360
- Genetics 187
- Hematology 182
- Pulmonary and Respiratory Medicine 358
Countries citing papers authored by Ed Cadman
This map shows the geographic impact of Ed Cadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Cadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Cadman more than expected).
Fields of papers citing papers by Ed Cadman
This network shows the impact of papers produced by Ed Cadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Cadman. The network helps show where Ed Cadman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ed Cadman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 37 | |
| 2 | 1986 | 11 | |
| 3 | 1985 | 79 | |
| 4 | Cytotoxicity of several chemotherapeutic agents in a human pancreatic cancer cell line (Colo-357). | 1984 | 3 |
| 5 | 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow. | 1983 | 41 |
| 6 | 1983 | 12 | |
| 7 | 1983 | 12 | |
| 8 | Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60. | 1983 | 7 |
| 9 | 1982 | 41 | |
| 10 | Phase I pilot study using 24 hour sequenced methotrexate and 5-fluorouracil | 1982 | 1 |
| 11 | Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors. | 1982 | 10 |
| 12 | 1981 | 23 | |
| 13 | Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells. | 1981 | 11 |
| 14 | Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts. | 1980 | 8 |
| 15 | Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure. | 1980 | 51 |
| 16 | Enhanced 5-fluorouracil (5-fu) nucleotide formation following methotrexate (mtx) is the consequence of increased intracellular phosphoribosylpyrophosphate (prpp). Abstr. | 1979 | 2 |
| 17 | Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells. | 1978 | 26 |
| 18 | 1977 | 1 | |
| 19 | 1977 | 6 | |
| 20 | 1976 | 8 |
About Ed Cadman
Ed Cadman is a scholar working on Cancer Research, Oncology, Biochemistry, Molecular Biology and Genetics, having authored 58 papers that have together received 1.6k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (20 papers), Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Oncology (696 citations), Pathology and Forensic Medicine (360 citations), Genetics (187 citations), Hematology (182 citations) and Pulmonary and Respiratory Medicine (358 citations). Ed Cadman has collaborated with scholars based in United States. Frequent co-authors include Robert Heimer, Joseph R. Bertino, Chris Benz, Lynn Davis, Robert L. Capizzi, Christopher C. Benz, Leonard R. Farber, R.D. Armstrong, Frank J. Rauscher and Leonard R. Prosnitz. Their work appears in journals such as Cancer, Cancer Chemotherapy and Pharmacology, Biochemical Pharmacology, Analytical Biochemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.